Booster shot for Moms-to-Be: new study tracks GBS vaccine protection
NCT ID NCT06592586
First seen Jan 31, 2026 · Last updated May 12, 2026 · Updated 16 times
Summary
This study follows healthy pregnant women who previously received an experimental Group B Streptococcus (GBS) vaccine to see how long their immune protection lasts. It also tests whether a booster dose given during a new pregnancy is safe and boosts immunity, aiming to protect newborns from serious infections like sepsis and meningitis. About 338 participants in Denmark and South Africa are involved.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus Universitetshospital
Aarhus N, Central Jutland, 8200, Denmark
-
Hvidovre Hospital - Department Of Obstetrics And Gynaecology
Copenhagen, Capital Region, 2650, Denmark
-
Sefako Makgatho Health Sciences University, Medunsa Clinical Research Unit (MeCRU)
Ga-Rankuwa, Gauteng, 0204, South Africa
-
Setshaba Research Centre
Pretoria, Guateng Province, 0152, South Africa
-
Sygehus Lillebælt - Kolding Sygehus
Kolding, Region Syddanmark, 6000, Denmark
-
Wits Reproductive Health and HIV Institute (Wits RHI)
Johannesburg, Guateng Province, 2001, South Africa
Conditions
Explore the condition pages connected to this study.